Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors

Sponsor
M.D. Anderson Cancer Center (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05305950
Collaborator
(none)
60
1
12.5
4.8

Study Details

Study Description

Brief Summary

This study aims to identify the modifiable facilitators and barriers to occupational and physical therapy care for children during and after cancer treatment that may be contributing to disparities in health outcomes. The investigators will identify these facilitators and barriers by surveying and interviewing healthcare administrators at MD Anderson Cancer center. The investigators will also survey and interview physicians, advanced practice providers, and occupational and physical therapists to obtain their feedback on these issues.

Condition or Disease Intervention/Treatment Phase
  • Other: Patient population

Study Design

Study Type:
Observational
Anticipated Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Exploring Barriers and Facilitators to Mitigate Disparities in Access to OT/PT in Pediatric Cancer Survivors
Actual Study Start Date :
Dec 17, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Healthcare administrators

Healthcare administrators at MD Anderson Cancer Center and the sister institutions

Other: Patient population
Questionnaire, standard of care

Physicians/referring providers

Physicians/referring providers and the occupational therapy (OT) and physical therapy (PT) therapists at MD Anderson Cancer Center and the sister institutions

Other: Patient population
Questionnaire, standard of care

Outcome Measures

Primary Outcome Measures

  1. Identify modifiable barriers to occupational and physical therapy care for children during cancer treatment that may be contributing to disparities in health outcomes. [Through study completion, an average of 1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Aim 1 Inclusion Criteria:
  • Employed as an administrator at MD Anderson Cancer Center and the sister institutions and working in the areas of pediatrics, survivorship, cancer control, health policy, and rehabilitation services.
Aim 2 Inclusion Criteria:
  • Employed as a referring provider (e.g., oncologist, surgeon, advanced care practitioner), or an OT/PT therapist at MD Anderson Cancer Center and the sister institutions.
Exclusion Criteria:
  • Inability to provide informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 M D Anderson Cancer Center Houston Texas United States 77030

Sponsors and Collaborators

  • M.D. Anderson Cancer Center

Investigators

  • Principal Investigator: Karen Moody, MD, M.D. Anderson Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT05305950
Other Study ID Numbers:
  • 2021-0893
  • NCI-2021-12740
First Posted:
Mar 31, 2022
Last Update Posted:
Aug 24, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 24, 2022